Risk Factors for Nonalcoholic Fatty Liver Disease in Postmenopausal Women with Type 2 Diabetes Mellitus and the Correlation with Bone Mineral Density at Different Locations

References

• Jian-gao F; Chinese Liver Disease Association. Guidelines for management of nonalcoholic fatty liver disease: an updated and revised edition. Zhonghua Gan Zang Bing Za Zhi. 2010;18(3):163–166.
   PubMedGoogle Scholar
• Li J, Zou B, Yeo YH, et al. Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999–2019: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2019;4(5):389–398. doi:10.1016/S2468-1253(19)30039-1
   PubMed Web of Science ®Google Scholar
• Wang L, Gao P, Zhang M, et al. Prevalence and ethnic pattern of diabetes and prediabetes in China in 2013. JAMA. 2017;317(24):2515–2523. doi:10.1001/jama.2017.7596
   PubMed Web of Science ®Google Scholar
• Moon SS, Lee YS, Kim SW. Association of nonalcoholic fatty liver disease with low bone mass in postmenopausal women. Endocrine. 2012;42(2):423–429. doi:10.1007/s12020-012-9639-6
   PubMed Web of Science ®Google Scholar
• Cui R, Sheng H, Rui XF, et al. Low bone mineral density in Chinese adults with nonalcoholic Fatty liver disease. Int J Endocrinol. 2013;2013:396545. doi:10.1155/2013/396545
   Web of Science ®Google Scholar
• Lee SH, Yun JM, Kim SH, et al. Association between bone mineral density and nonalcoholic fatty liver disease in Korean adults. J Endocrinol Invest. 2016;39(11):1329–1336. doi:10.1007/s40618-016-0528-3
   Web of Science ®Google Scholar
• Bhatt SP, Nigam P, Misra A, Guleria R, Qadar Pasha MA. Independent associations of low 25 hydroxy vitamin D and high parathyroid hormonal levels with nonalcoholic fatty liver disease in Asian Indians residing in north India. Atherosclerosis. 2013;230(1):157–163. doi:10.1016/j.atherosclerosis.2013.07.006
   Web of Science ®Google Scholar
• Wang Z, Xu M, Hu Z, Shrestha UK. Prevalence of nonalcoholic fatty liver disease and its metabolic risk factors in women of different ages and body mass index. Menopause. 2015;22(6):667–673. doi:10.1097/GME.0000000000000352
   PubMed Web of Science ®Google Scholar
• Wong VW, Wong GL, Yeung DK, et al. Incidence of non-alcoholic fatty liver disease in Hong Kong: a population study with paired proton-magnetic resonance spectroscopy. J Hepatol. 2015;62(1):182–189. doi:10.1016/j.jhep.2014.08.041
   PubMed Web of Science ®Google Scholar
• Ryu S, Suh BS, Chang Y, et al. Menopausal stages and non-alcoholic fatty liver disease in middle-aged women. Eur J Obstet Gynecol Reprod Biol. 2015;190:65–70. doi:10.1016/j.ejogrb.2015.04.017
   PubMed Web of Science ®Google Scholar
• Goldshtein I, Nguyen AM, dePapp AE, et al. Epidemiology and correlates of osteoporotic fractures among type 2 diabetic patients. Arch Osteoporos. 2018;13(1):15. doi:10.1007/s11657-018-0432-x
   Web of Science ®Google Scholar
• Sözen T, Özışık L, Başaran NÇ. An overview and management of osteoporosis. Eur J Rheumatol. 2017;4(1):46–56. doi:10.5152/eurjrheum.2016.048
   PubMed Web of Science ®Google Scholar
• American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2013;36 Suppl 1(Suppl1):S67–S74. doi:10.2337/dc13-S067
   Web of Science ®Google Scholar
• Wong VW, Chan WK, Chitturi S, et al. Asia-pacific working party on non-alcoholic fatty liver disease guidelines 2017-part 1: definition, risk factors and assessment. J Gastroenterol Hepatol. 2018;33(1):70–85. doi:10.1111/jgh.13857
   PubMed Web of Science ®Google Scholar
• WHO Sicentific Group on the assessment of osteoporosis at primary health care level. Summary meeting report, Brussels, Belgium; 2004.
   Google Scholar
• Fihn SD, Blankenship JC, Alexander KP, et al. 2014 ACC/AHA/AATS/PCNA/SCAI/STS focused update of the guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, and the American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2014;64(18):1929–1949. doi:10.1016/j.jacc.2014.07.017
   PubMed Web of Science ®Google Scholar
• Williams B, Mancia G, Spiering W, et al.; ESC Scientific Document Group. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018;39(33):3021–3104. doi:10.1093/eurheartj/ehy339
   PubMed Web of Science ®Google Scholar
• Sacco RL, Kasner SE, Broderick JP, et al.; American Heart Association Stroke Council, Council on Cardiovascular Surgery and Anesthesia; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular and Stroke Nursing; Council on Epidemiology and Prevention; Council on Peripheral Vascular Disease; Council on Nutrition, Physical Activity and Metabolism. An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2013;44(7):2064–2089. doi:10.1161/STR.0b013e318296aeca
   PubMed Web of Science ®Google Scholar
• Yu KH, Chen DY, Chen JH, et al. Management of gout and hyperuricemia: multidisciplinary consensus in Taiwan. Int J Rheum Dis. 2018;21(4):772–787. doi:10.1111/1756-185X.13266
   PubMed Web of Science ®Google Scholar
• Psychari SN, Rekleiti N, Papaioannou N, et al. Epicardial fat in nonalcoholic fatty liver disease: properties and relationships with metabolic factors, cardiac structure, and cardiac function. Angiology. 2016;67(1):41–48. doi:10.1177/0003319715576672
   Web of Science ®Google Scholar
• Borai IH, Shaker Y, Kamal MM, et al. Evaluation of biomarkers in egyptian patients with different grades of nonalcoholic fatty liver disease. J Clin Transl Hepatol. 2017;5(2):109–118. doi:10.14218/JCTH.2017.00004
   Web of Science ®Google Scholar
• Pang Y, Kartsonaki C, Turnbull I, et al. Diabetes, plasma glucose, and incidence of fatty liver, cirrhosis, and liver cancer: a prospective study of 0.5 million people. Hepatology. 2018;68(4):1308–1318. doi:10.1002/hep.30083
   PubMed Web of Science ®Google Scholar
• Hagström H, Tynelius P, Rasmussen F. High BMI in late adolescence predicts future severe liver disease and hepatocellular carcinoma: a national, population-based cohort study in 1.2 million men. Gut. 2018;67(8):1536–1542. doi:10.1136/gutjnl-2016-313622
   PubMed Web of Science ®Google Scholar
• Ma H, Xu C, Xu L, Yu C, Miao M, Li Y. Independent association of HbA1c and nonalcoholic fatty liver disease in an elderly Chinese population. BMC Gastroenterol. 2013;13:3. doi:10.1186/1471-230X-13-3
   PubMed Web of Science ®Google Scholar
• Chen CX, Du J, Xu YM, et al. Predictive value of serum glycosylated hemoglobin for the onset of nonalcoholic fatty liver disease. Zhonghua Gan Zang Bing Za Zhi. 2018;20(26):765–770.
   Google Scholar
• Younossi ZM, Koenig AB, Abdelatif D, et al. Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64(1):73–84. doi:10.1002/hep.28431
   PubMed Web of Science ®Google Scholar
• Chen Y, Huang Q, Ai P, et al. Association between serum uric acid and non-alcoholic fatty liver disease according to Different Menstrual Status Groups. Can J Gastroenterol Hepatol. 2019;2019:2763093. doi:10.1155/2019/2763093
   PubMed Web of Science ®Google Scholar
• Du Y, Pan T, Zhong X, et al. Study on the relationship between serum uric acid level and body mass index, blood lipids and renal function in postmenopausal women with type 2 diabetes mellitus. Acta Universitatis Medicinalis Anhui. 2017;52(8):1219–1223.
   Google Scholar
• Dong-Yun L, Kyung J, Hur KY, et al. Association between nonalcoholic fatty liver disease and bone mineral density in postmenopausal women. Climacteric. 2018;21(5):498–501. doi:10.1080/13697137.2018.1481380
   Web of Science ®Google Scholar
• Targher G, Day CP, Bonora E. Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. N Engl J Med. 2010;363:1341–1350. doi:10.1056/NEJMra0912063
   PubMed Web of Science ®Google Scholar
• Wild SH, Walker JJ, Morling JR, et al. Cardiovascular disease, cancer, and mortality among people with type 2 diabetes and alcoholic or nonalcoholic fatty liver disease hospital admission. Diabetes Care. 2018;4l(2):341–347. doi:10.2337/dc17-1590
   Web of Science ®Google Scholar
• Lee SB, Park GM, Lee JY, et al. Association between non-alcoholic fatty liver disease and subclinical coronary atherosclerosis: an observational cohort study. J Hepatol. 2018;68(5):1018–1024. doi:10.1016/j.jhep.2017.12.012
   Web of Science ®Google Scholar
• Zhu X, Yan H, Chang X, et al. Association between non-alcoholic fatty liver disease-associated hepatic fibrosis and bone mineral density in postmenopausal women with type 2 diabetes or impaired glucose regulation. BMJ Open Diabetes Res Care. 2020;Aug(1):e000999. doi:10.1136/bmjdrc-2019-000999
   Web of Science ®Google Scholar